Skip to main content
. 2022 Jul 12;13:821616. doi: 10.3389/fphar.2022.821616

TABLE 3.

How to efficiently manage a switch from a biological reference product to a biosimilar or vice versa and inform the patient: guiding principles from structured healthcare professional group discussions.

Level of agreement a Level of consensus b
When implementing a switch it is important to…
General elements
  A. Communicate with a one voice principle (coherence in communication and terminology used among physicians, pharmacists, nurses) 4.7 Strong consensus
  B. Search for consensus and support from involved stakeholders prior to the switch 4.5 Strong consensus
  C. Inform/educate/train involved physicians, pharmacists, nurses about the switch and/or general concepts of biosimilars 4.3 Strong consensus
  D. Follow a planned and stepwise approach 3.9 Moderate consensus
Elements related to the patient
  A. In the hospital setting: inform patients in advance about the switch 3.7 Moderate consensus
  B. For subcutaneous (self-administered) products: inform patients about the switch and involve them in the decision-making 4.5 Strong consensus
  C. Provide an opportunity to discuss the switch with the physician/nurse prior to the switch, provide patients with the opportunity to ask questions 4.5 Strong consensus
  D. For subcutaneous products (self-administered): provide training to the patient on the new injection device 4.6 Strong consensus
  E. Keep it simple. Providing patients with excessive information may invoke uncertainty about the change/biosimilar 4.5 Strong consensus
  F. Assess the information need on the individual patient level 4.3 Strong consensus
  G. Frame the switch positively, and focus on equality of the treatments 4.7 Strong consensus
  H. Allow room for deviation in case a patient objects to switch 3.7 Moderate consensus
a

Participants expressed their level of agreement (LoA) on a five-point Likert scale, with 1 = strongly disagree to 5 = strongly agree. This column shows the calculated mean LoA.

b

Strong consensus: when at least 80% of participants agreed with the statement (yes/no) and the mean overall LoA was ≥4 on the Likert scale, Moderate consensus: a mean overall LoA of ≥3.5 on the Likert-scale, No consensus: a mean overall LoA of <3.5 on the Likert scale.